Figure 3
Design of important clinical trials comparing aromatase inhibitors alone vs aromatase inhibitors given in combinations with novel targeted therapies. MBC=metastatic breast cancer; NST-AI=nonsteroidal aromatase inhibitor; PMW=postmenopausal women.
